Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A
Pharmacology, Toxicology and Pharmaceutical Science
8
10%
Biochemistry, Genetics and Molecular Biology
3
4%
Nursing and Health Professions
2
2%
Other
13
16%
Unknown
24
30%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2026.
All research outputs
#3,809,557
of 34,559,526 outputs
Outputs from Journal of Thrombosis & Haemostasis
#963
of 5,385 outputs
Outputs of similar age
#28,057
of 249,122 outputs
Outputs of similar age from Journal of Thrombosis & Haemostasis
#6
of 39 outputs
Altmetric has tracked 34,559,526 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,385 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,122 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.
